Response to: 'Hydroxychloroquine shortages during the COVID-19 pandemic' by Mendel et al
- PMID: 32434826
- DOI: 10.1136/annrheumdis-2020-217954
Response to: 'Hydroxychloroquine shortages during the COVID-19 pandemic' by Mendel et al
Keywords: hydroxychloroquine; immune complex diseases; inflammation.
Conflict of interest statement
Competing interests: None declared.
Comment on
-
COVID-19 and rheumatology: first steps towards a different future?Ann Rheum Dis. 2020 May;79(5):551-552. doi: 10.1136/annrheumdis-2020-217494. Ann Rheum Dis. 2020. PMID: 32299844 No abstract available.
-
Hydroxychloroquine shortages during the COVID-19 pandemic.Ann Rheum Dis. 2021 Mar;80(3):e31. doi: 10.1136/annrheumdis-2020-217835. Epub 2020 May 20. Ann Rheum Dis. 2021. PMID: 32434820 No abstract available.

